Search This Blog

Thursday, August 8, 2019

Cytokinetics EPS misses by $0.06, beats on revenue

Cytokinetics (NASDAQ:CYTK): Q2 GAAP EPS of -$0.56 misses by $0.06.
Revenue of $7.1M (+14.5% Y/Y) beats by $0.11M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)